You are here

Pyxis

After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B

Fierce Biotech

Tue, 03/30/21 - 11:49 am

venture capital

antibody-drug conjugate

Bayer-backed Pyxis debuts with $22M to pursue new immuno-oncology targets

BioCentury

Wed, 07/17/19 - 11:06 pm

immuno-oncology

MD Anderson Signs Contract For Pyxis ES Technology From CareFusion

Yahoo/PRNewswire

Tue, 06/11/13 - 09:55 pm

Hospitals Reduce Medication Errors up to 33 Percent Using CareFusion Technology

Wed, 12/1/10 - 04:27 pm